Vimarsana
Biggest News Aggregation in the World

Page 47 - Randomized Clinical News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Randomized Clinical. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Randomized Clinical Today - Breaking & Trending Today

Medically, you might be interested in... - Vimarsana News

Medically, you might be interested in...

A regular series on the latest clinical studies from around the world – and what they mean ‘in practice’, compiled and written by Clare GP Dr Ray O’Connor

Source: imt.ie
The ugly history of vitamin D3 and Fauci's pro-vaccine bias -- Health & Wellness -- Sott.net - Vimarsana News

The ugly history of vitamin D3 and Fauci's pro-vaccine bias -- Health & Wellness -- Sott.net

We had an inexpensive life-saving solution both before and during the pandemic... The inconvenient truth is that even at the beginning of the COVID-19 pandemic, a very simple, inexpensive and effective treatment was available that could have...

Source: sott.net
Preventable Deaths and D3. - Vimarsana News

Preventable Deaths and D3.

We had an inexpensive life-saving solution both before and during the pandemic… The inconvenient truth is that even ...

JAMA Neurology Publishes Phase 3 Study Results on the Efficacy and Safety of FINTEPLA® (fenfluramine) Oral Solution in Lennox-Gastaut Syndrome (LGS) - Vimarsana News

JAMA Neurology Publishes Phase 3 Study Results on the Efficacy and Safety of FINTEPLA® (fenfluramine) Oral Solution in Lennox-Gastaut Syndrome (LGS)

Primary endpoint was met demonstrating that FINTEPLA, as adjunctive treatment, is effective in significantly reducing the frequency of drop seizures in LGS...

JAMA Neurology Publishes Phase 3 Study Results on the Efficacy and Safety of FINTEPLA® (fenfluramine) Oral Solution in Lennox-Gastaut Syndrome (LGS) - Vimarsana News

JAMA Neurology Publishes Phase 3 Study Results on the Efficacy and Safety of FINTEPLA® (fenfluramine) Oral Solution in Lennox-Gastaut Syndrome (LGS)

Primary endpoint was met demonstrating that FINTEPLA, as adjunctive treatment, is effective in significantly reducing the frequency of drop seizur...